ActiveSight to Provide Crystallography Services to Inpharmatica
News Nov 23, 2005
ActiveSight has announced that it has signed an agreement to provide structural biology services to Inpharmatica Ltd.
The agreement focuses on co-crystallography by ActiveSight of certain Inpharmatica small molecules with a human drug target protein. The agreement includes upfront fees and payments for milestones.
"ActiveSight is delighted to augment Inpharmatica's unique drug discovery platform," stated Duncan McRee, Ph.D., President of ActiveSight.
Bicycle Therapeutics Expands Strategic Partnership with AstraZenecaNews
New programs added in respiratory and cardio-metabolic diseases.READ MORE
Worldwide Clinical Trials Receives 2018 CRO Leadership AwardsNews
Life Science Leader and Industry Standard Research assess 70 contract research organizations, honoring Worldwide Clinical Trials for fifth consecutive year.READ MORE
WuXi Biologics to Invest in Biologics Manufacturing Facility in SingaporeNews
WuXi Biologics' first overseas site in Asia.READ MORE
Comments | 0 ADD COMMENT
2nd Annual Artificial Intelligence in Drug Development Congress
Sep 20 - Sep 21, 2018